Rao P V, Krishna C M, Zigler J S
Laboratory of Mechanisms of Ocular Diseases, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892.
J Biol Chem. 1992 Jan 5;267(1):96-102.
zeta-Crystallin is a major protein in the lens of certain mammals. In guinea pigs it comprises 10% of the total lens protein, and it has been shown that a mutation in the zeta-crystallin gene is associated with autosomal dominant congenital cataract. As with several other lens crystallins of limited phylogenetic distribution, zeta-crystallin has been characterized as an "enzyme/crystallin" based on its ability to reduce catalytically the electron acceptor 2,6-dichlorophenolindophenol. We report here that certain naturally occurring quinones are good substrates for the enzymatic activity of zeta-crystallin. Among the various quinones tested, the orthoquinones 1,2-naphthoquinone and 9,10-phenanthrenequinone were the best substrates whereas menadione, ubiquinone, 9,10-anthraquinone, vitamins K1 and K2 were inactive as substrates. This quinone reductase activity was NADPH specific and exhibited typical Michaelis-Menten kinetics. Activity was sensitive to heat and sulfhydryl reagents but was very stable on freezing. Dicumarol (Ki = 1.3 x 10(-5) M) and nitrofurantoin (Ki = 1.4 x 10(-5) M) inhibited the activity competitively with respect to the electron acceptor, quinone. NADPH protected the enzyme against inactivation caused by heat, N-ethylmaleimide, or H2O2. Electron paramagnetic resonance spectroscopy of the reaction products showed formation of a semiquinone radical. The enzyme activity was associated with O2 consumption, generation of O2- and H2O2, and reduction of ferricytochrome c. These properties indicate that the enzyme acts through a one-electron transfer process. The substrate specificity, reaction characteristics, and physicochemical properties of zeta-crystallin demonstrate that it is an active NADPH:quinone oxidoreductase distinct from quinone reductases described previously.
ζ-晶状体蛋白是某些哺乳动物晶状体中的一种主要蛋白质。在豚鼠中,它占晶状体总蛋白的10%,并且已经表明ζ-晶状体蛋白基因的突变与常染色体显性先天性白内障有关。与其他几种系统发育分布有限的晶状体结晶蛋白一样,ζ-晶状体蛋白基于其催化还原电子受体2,6-二氯酚靛酚的能力被表征为一种“酶/结晶蛋白”。我们在此报告,某些天然存在的醌是ζ-晶状体蛋白酶活性的良好底物。在测试的各种醌中,邻醌1,2-萘醌和9,10-菲醌是最佳底物,而甲萘醌、泛醌、9,10-蒽醌、维生素K1和K2作为底物无活性。这种醌还原酶活性对NADPH具有特异性,并表现出典型的米氏动力学。活性对热和巯基试剂敏感,但在冷冻时非常稳定。双香豆素(Ki = 1.3×10^(-5) M)和呋喃妥因(Ki = 1.4×10^(-5) M)相对于电子受体醌竞争性抑制活性。NADPH保护该酶免受热、N-乙基马来酰亚胺或H2O2引起的失活。反应产物的电子顺磁共振光谱显示形成了半醌自由基。酶活性与氧气消耗、超氧阴离子和过氧化氢的产生以及铁细胞色素c的还原有关。这些特性表明该酶通过单电子转移过程起作用。ζ-晶状体蛋白的底物特异性、反应特征和物理化学性质表明它是一种活性NADPH:醌氧化还原酶,不同于先前描述的醌还原酶。